Browsing byAuthorGood, P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 61 to 71 of 71< previous 
Issue DateTitleAuthor(s)
2024-02-10The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life.Haupt, LM; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Pharasi, A; Zunk, M; George, R; Griffiths, LR; Good, P; Hardy, J
2017-04The Liminal and the Parallax: Living and Dying at the End of Life.MacArtney, JI; Broom, A; Kirby, E; Good, P; Wootton, J
2018-08The meaning and experience of bereavement support: A qualitative interview study of bereaved family caregivers.Kirby, E; Kenny, K; Broom, A; MacArtney, J; Good, P
2018-01-01The other side of “getting by”: A case study of interpreting provision decision-making and consequences for patientsAbbato, S; Ryan, J; Skelly, C; Good, P
2024-08-21Top Ten Tips Palliative Care Clinicians Should Know About Designing a Clinical Trial in Palliative Care.Gurgenci, T; O'Leary, C; Philip, J; Bruera, E; Davis, M; Agar, MR; Hui, D; Zimmermann, C; Yennu, S; Hardy, J; Mercadante, S; Rosa, WE; Good, P
2024-07-24Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial.Gurgenci, T; O'Leary, C; Hui, D; Yennu, S; Bruera, E; Davis, M; Agar, MR; Zimmermann, C; Philip, J; Mercadante, S; Hardy, J; Rosa, WE; Good, P
2014-02-01The troubles of telling: Managing communication about the end of lifeBroom, A; Kirby, E; Good, P; Wootton, J; Adams, J
2023-01-01Understanding priorities of care: An assessment of FAMCARE-2 satisfaction surveys and thematic analysis in community palliative careCooper, M; Fischer, A; Dubrowin, N; Kilkenny, C; Good, P
2022-09-05Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.Olson, RE; Smith, A; Huggett, G; Good, P; Dudley, M; Hardy, J
2023-02'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.Olson, RE; Smith, A; Good, P; Dudley, M; Gurgenci, T; Hardy, J
2019-02-01Why is optimisation of antimicrobial use difficult at the end of life?Broom, J; Broom, A; Good, P; Lwin, Z